Login to Your Account

Pharma: Other News To Note

Monday, March 25, 2013

• Simcere Pharmaceutical Group, of Nanjing, China, said the Chinese State Food and Drug Administration issued its approval for GMP certification of the influenza vaccine production facility at subsidiary Jiangsu Simcere Vaxtec Bio-Pharmaceutical Co. Ltd.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription